A consortium of four Fraunhofer Institutes (the Fraunhofer Institute for Cell Therapy and Immunology IZI, Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, Fraunhofer Institute for Manufacturing Engineering and Automation IPA, and the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB) is developing a way of inactivating viruses and other pathogens based on low energy electron irradiation. This may aid the manufacture of more effective, safe and also more cost-effective vaccines.
Since as early as the 1950s, toxic chemicals such as formaldehyde have been used to inactivate pathogens for so-called killed vaccines (e.g. to fight influenza, polio or hepatitis A viruses). This procedure, which has barely changed since, marked a milestone in infection biology at the time, however it is still subject to various limitations to this day.
The chemical treatment, which can last several weeks, also destroys some of the pathogens' surface structures that the immune system could use to recognize and attack following infection. Drugs manufactured in this way either have to be administered in high concentrations or have to be boosted at regular intervals in order to offer sufficient protection – a fact that hampers their use in poorer and structurally weak countries.
“Inactivation by means of low energy electron irradiation could well be the next major milestone in vaccine research,” remarks Project Manager Dr. Sebastian Ulbert from Fraunhofer IZI, summing up the advantages of the new technology. The Fraunhofer consortium has been working for three years on this alternative technology for inactivation through application of low energy electron irradiation.
The project results show that the technology is fundamentally applicable to an entire spectrum of different types of virus (e.g. polio or influenza) as well as other kinds of pathogen (bacteria, parasites). Irradiation destroys the genetic substance the viruses need to multiply. Unlike chemical inactivation using formaldehyde, the structural proteins (antigens) that are vital to the immune response remain intact.
The hope is that this enables to the body to form much more specific antibodies against the pathogens, keeping it better protected. Ultimately, lower doses may be able to be used in vaccinations.
With a grant of USD 1.85 million, the Bill & Melinda Gates Foundation is now funding the application of the irradiation technology in order to develop a new polio vaccine (Grant Agreement Investment ID: OPP1154635).
Fraunhofer FEP and Fraunhofer IPA are jointly developing the basic design of a prototype for an automated irradiation installation. This experimental unit should be installed at Fraunhofer IZI in Leipzig by autumn 2018. In this way, a novel, compact, and highly efficient technology for producing safe economical vaccines will be developed through the application of low-energy electron radiation. The Fraunhofer IGB is working in collaboration with the Fraunhofer IZI on the manufacturing and immunological characterization of the pathogens.
Further information about the Bill & Melinda Gates Foundation:
Annett Arnold | Fraunhofer-Institut für Organische Elektronik, Elektronenstrahl- und Plasmatechnik FEP
Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland
Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy